Pluristem’s PLX Cells Show Efficacy in Treating Lung Disease
July 31, 2012 - (Pluristem) - "Pluristem Therapeutics, Inc, a leading developer of placenta-based cell therapies, today announced the results of new preclinical tests that show its PLacental eXpanded (PLX) cells may be effective in reducing pulmonary fibrosis and improving lung function in a group of diseases collectively called interstitial lung disease (ILD). ILD includes the pulmonary insults occurring in the lung following its exposure to drugs, radiation or toxic chemicals and the pulmonary complications of systemic autoimmune diseases." Read Full Article
